Biomarkers enable prediction of tacrolimus resistance in patients with severe allergic conjunctivitis. Okada N, Yazu H, Shimizu E, Fukagawa K, et al. Allergy 2022 Sep 30. doi: 10.1111/all.15535.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Okada N, Yazu H, Shimizu E, Fukagawa K, et al. Biomarkers enable prediction of tacrolimus resistance in patients with severe allergic conjunctivitis. Allergy 2022 Sep 30. doi: 10.1111/all.15535.
PMID: 36178061